Clinical Significance:
ALT/GPT is present in high concentration in liver and to a lesser extent in kidney, heart, skeletal muscle, pancreas, spleen and lung. Increased levels of ALT/GPT however is generally a result of liver disease associated with some degree of hepatic necrosis such as cirrhosis, viral or toxic hepatitis and obstructive jaundice. Characteristically ALT/GPT is generally higher than AST/GPT in acute viral or toxic hepatitis, whereas for most patients with chronic hepatic disease, ALT/GPT levels are generally lower than AST/GPT levels. Elevated ALT/GPT levels have also been found in extensive trauma and muscle disease, circulatory failure with shock, hypoxia, myocardial infarction and haemolytic disease.
Packaging Information:
| Method |
Pack Type |
Pack Size |
Product Code |
| IFCC |
System Pack |
R1: 4 x 34 ml; R2: 4 x 17 ml |
120272 |
| R1: 6 x 44 ml; R2: 3 x 22 ml |
120617 |
| R1: 5 x 22; R2: 5 x 11 ml |
121173 |